Lobbyist information

Amount

George Atanasov

$53,768.75

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2019 Areas of focus will be any issues that impact Johnson & Johnson companies, including but not limited to medical device, consumer, pharmaceuticals, health care reform, wellness initiatives, tax and environment. Contacts related to these issues are expected to be made with the Executive Offices of the Governor and Lieutenant Governor, the Office of the Secretary of Health and Human Services, the Department of Public Health, the Health Policy Commission, the Department of Environmental Protection as well as the Legislature. Bills or issues of likely focus (with reference to bill numbers, where applicable, as assigned for the 2017-18 legislative session): SB 652, An Act to promote transparency and prevent price gouging of pharmaceutical drug prices; SB 627, An Act to promote transparency in prescription drug prices; HB 490, An Act relative to ensuring transparency of health plan formularies; HB 1228, An Act to promote transparency and cost control of pharmaceutical drug prices; HB 3223, An Act to promote transparency in prescription drug prices; SB 516, An Act relative to out-of-pocket expenses for prescription drug coverage; SB 550, An Act relative to ensuring transparency of health plan formularies; SB 637, An Act to define modest meals and refreshments in prescriber education settings; SB 1163, An Act relative to transparency and access in healthcare; SB 1209, An Act relative to the in-office sales of medical devices and products; SB 1215, An Act to reduce healthcare costs by promoting non-biased prescriber education; SB 1233, An Act to restore integrity in the marketing of pharmaceutical products and medical devices; HB 2371, An Act relative to non-competition agreements; SB 1020, An Act to protect trade secrets and eliminate non-compete agreements; HB 143, An Act relative to the digital right to repair; SB 96, An Act relative to the digital right to repair; Advocacy for the Department of Public Health to commence promulgation of regulations relative to a pharmacist's authority under the law to administer injections of certain mental health and substance abuse medications; FY 19 budget Continued Implementation of Chapter 224; and Economic Development Policies.

Total salaries paid:      $53,768.75

Lobbyist Entity information

Amount

ML Strategies, LLC	$55,500.00
Employed Terminated 01/01/2019

Total salaries paid:      $55,500.00

Expenditures

Amount